<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Rifampicin: compound preparations; Rifinah" /><meta name="IX" content="Rifampicin: compound preparations; Rifinah" /><title>Rifinah® 300/150: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP3633-rifinah-300150.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP3633-rifinah-300150.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP3633-rifinah-300150.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 08 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP3253-infections.htm">5 Infections</a> &gt; <a href="PHP3256-antibacterial-drugs.htm">5.1 Antibacterial drugs</a> &gt; <a href="PHP3588-antituberculosis-drugs.htm">5.1.9 Antituberculosis drugs</a> &gt; <a href="PHP3631-rifampicin-with-isoniazid.htm">RIFAMPICIN WITH ISONIAZID</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP3619-rifampicin.htm" title="Previous: RIFAMPICIN">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP3636-streptomycin.htm" title="Next: STREPTOMYCIN">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a382401.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Isoniazid</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Anti-infective Agents 8:00 &gt; Antimycobacterials 8:16 &gt; Antituberculosis Agents 8:16.04</p></div></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a382403.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Rifampin</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Anti-infective Agents 8:00 &gt; Antimycobacterials 8:16 &gt; Antituberculosis Agents 8:16.04</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/7559-k.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Isoniazid</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: I &gt; Interactions of Isoniazid</p></div></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/7569-t.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Rifampicin</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: R &gt; Interactions of Rifampicin</p></div></li></ul><ul><li><h3>British National Formulary (12)</h3></li><li><a href="PHP3588-antituberculosis-drugs.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">5.1.9 Antituberculosis drugs</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 5 Infections &gt; 5.1 Antibacterial drugs</p></div></li><li><a href="PHP3608-isoniazid.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">ISONIAZID</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 5 Infections &gt; 5.1 Antibacterial drugs &gt; 5.1.9 Antituberculosis drugs</p></div></li><li><a href="PHP3610-isoniazid-non-proprietary.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Isoniazid</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 5 Infections &gt; 5.1 Antibacterial drugs &gt; 5.1.9 Antituberculosis drugs &gt; ISONIAZID</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22rifampicin+with+isoniazid%22%22rifampicin%22%22isoniazid%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (12)</a></li></ul><ul><li><h3>BNF for Children (15)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP12633-prevention-of-secondary-case-of-meningococcal-meningitis.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Prevention of secondary case of meningococcal meningitis</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 5 Infections &gt; 5.1 Antibacterial drugs &gt; Table 2. Summary of antibacterial prophylaxis</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP12634-prevention-of-secondary-case-of-haemophilus-influenzae-type-b-disease.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Prevention of secondary case of Haemophilus influenzae type b disease</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 5 Infections &gt; 5.1 Antibacterial drugs &gt; Table 2. Summary of antibacterial prophylaxis</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP12639-prevention-of-tuberculosis-in-susceptible-close-contacts-or-those-who-have-become-tuberculin-positive.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Prevention of tuberculosis in susceptible close contacts or those who have become tuberculin positive</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 5 Infections &gt; 5.1 Antibacterial drugs &gt; Table 2. Summary of antibacterial prophylaxis</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22rifampicin+with+isoniazid%22%22rifampicin%22%22isoniazid%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (15)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK0899.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Isoniazid</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; I</p></div></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK1463.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Rifampicin</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; R</p></div></li></ul><ul><li><h3>Dietary Supplements (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/diet/2010/c97.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Vitamin B6</a><div class="breadcrumb"><p><strong>Dietary Supplements</strong> &gt; Monographs &gt; V</p></div></li><li><a href="http://www.medicinescomplete.com/mc/diet/2010/a02.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Appendix 2: Drug and supplement interactions</a><div class="breadcrumb"><p><strong>Dietary Supplements</strong> &gt; Monographs &gt; Appendices</p></div></li></ul><ul><li><h3>Handbook on Injectable Drugs</h3></li><li><a href="http://www.medicinescomplete.com/mc/hid/2010/a593006.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Rifampin</a><div class="breadcrumb"><p><strong>Handbook on Injectable Drugs</strong> &gt; Monographs &gt; R</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0009s0104.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Isoniazid</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; I</p></div></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0017s0089.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Rifampin</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; R</p></div></li></ul><ul><li><h3>Injectable Drugs Guide (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/idg/2010/A04-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Acetylcysteine</a><div class="breadcrumb"><p><strong>Injectable Drugs Guide</strong> &gt; Injectable Drugs Guide &gt; Monographs &gt; A</p></div></li><li><a href="http://www.medicinescomplete.com/mc/idg/2010/I10-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Isoniazid</a><div class="breadcrumb"><p><strong>Injectable Drugs Guide</strong> &gt; Injectable Drugs Guide &gt; Monographs &gt; I</p></div></li><li><a href="http://www.medicinescomplete.com/mc/idg/2010/r04-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Rifampicin (rifampin)</a><div class="breadcrumb"><p><strong>Injectable Drugs Guide</strong> &gt; Injectable Drugs Guide &gt; Monographs &gt; R</p></div></li></ul><ul><li><h3>Kucers' the Use of Antibiotics (14)</h3></li><li><a href="http://www.medicinescomplete.com/mc/kucers/2010/isoniazid_description.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Description</a><div class="breadcrumb"><p><strong>Kucers' the Use of Antibiotics</strong> &gt; Antibiotics &gt; Anti-Tuberculous Drugs &gt; 110 Isoniazid</p></div></li><li><a href="http://www.medicinescomplete.com/mc/kucers/2010/isoniazid_antimicrobial_activity.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Antimicrobial activity</a><div class="breadcrumb"><p><strong>Kucers' the Use of Antibiotics</strong> &gt; Antibiotics &gt; Anti-Tuberculous Drugs &gt; 110 Isoniazid</p></div></li><li><a href="http://www.medicinescomplete.com/mc/kucers/2010/isoniazid_mechanism_of_drug_action.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Mechanism of drug action</a><div class="breadcrumb"><p><strong>Kucers' the Use of Antibiotics</strong> &gt; Antibiotics &gt; Anti-Tuberculous Drugs &gt; 110 Isoniazid</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22rifampicin+with+isoniazid%22%22rifampicin%22%22isoniazid%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (14)</a></li></ul><ul><li><h3>Martindale: The Complete Drug Reference (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/7562-l.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Methaniazide</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Archive of Deleted Monographs &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/7559-k.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Isoniazid</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antibacterials &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/7569-t.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Rifampicin</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antibacterials &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/05186.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Isoniazid</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; I &gt; IS</p></div></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/08216.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Rifampin</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; R &gt; RI</p></div></li></ul><ul><li><h3>Remington: The Science and Practice of Pharmacy (4)</h3></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/c57-sec1-006.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Genetic Polymorphisms Influencing Drug Disposition</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 1: The Science of Pharmacy &gt; Section 6: Pharmacokinetics and Pharmacodynamics &gt; 57 Pharmacogenomics</p></div></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/mono-I86.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Isoniazid</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 3: Pharmaceutical and Medicinal Agents &gt; I</p></div></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/mono-R19.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Rifampin</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 3: Pharmaceutical and Medicinal Agents &gt; R</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22rifampicin+with+isoniazid%22%22rifampicin%22%22isoniazid%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (4)</a></li></ul><ul><li><h3>Stockley's Drug Interactions (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E2E3E0R0D104.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Isoniazid</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; I</p></div></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E4E3E0R0D104.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Rifampicin</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; R</p></div></li></ul><ul><li><h3>Drug Administration via Enteral Feeding Tubes (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c195.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Isoniazid</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; I</p></div></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c329.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Rifampicin</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; R</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1>RIFAMPICIN WITH ISONIAZID</h1><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h3 class="cO">Additional information</h3> <p class="cT"> interactions (<a href="bnf_int165-isoniazid.htm">Isoniazid</a>,<a href="bnf_int201-rifampicin.htm">Rifampicin</a>).</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Indications </h2> <p class="cT">tuberculosis, see <a title="BNF:sub-section: Antituberculosis drugs" href="PHP3588-antituberculosis-drugs.htm">notes above</a>; prevention of tuberculosis (Table 2, <a title="sub-topic: Prevention of tuberculosis  in susceptible close contacts or those who have become tuberculin positive" href="PHP3285-prevention-of-tuberculosis-in-susceptible-close-contacts-or-those-who-have-become-tuberculin-positive.htm">section 5.1</a>)</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Cautions </h2> <p class="cT">see Monitoring in <a title="BNF:target-block: Antituberculous drugs and liver monitoring" href="PHP3588-antituberculosis-drugs.htm#PHP3593">notes above</a>; also liver function tests and blood counts in hepatic disorders, alcohol dependence, and on prolonged therapy (see also below); slow acetylator status (increased risk of side-effects); epilepsy; history of psychosis; alcohol dependence, malnutrition, diabetes mellitus, HIV infection (risk of peripheral neuritis); acute porphyria (section <a title="sub-section: Acute porphyrias" href="PHP6363-acute-porphyrias.htm">9.8.2</a>); <strong>important:</strong> effectiveness of hormonal contraceptives is reduced and alternative family planning advice should be offered (see also section <a title="sub-section: Combined hormonal contraceptives" href="PHP4869-combined-hormonal-contraceptives.htm">7.3.1</a>); discolours soft contact lenses; see also notes above; <strong>interactions:</strong> Appendix 1 (rifamycins, isoniazid)</p></div> <div class="cG"><div class="cE"><h3 class="cT">Note</h3> <p class="cT">Increased risk of side-effects if treatment interrupted and then re-introduced</p></div></div> <div class="cG"><div class="cE"><h3 class="cT">Hepatic disorders</h3> <p class="cT">Patients or their carers should be told how to recognise signs of liver disorder, and advised to discontinue treatment and seek immediate medical attention if symptoms such as persistent nausea, vomiting, malaise, or jaundice develop</p></div></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Contra-indications </h2> <p class="cT">jaundice; drug-induced liver disease; rifamycin hypersensitivity</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Hepatic impairment </h2> <p class="cT">impaired elimination; avoid or do not exceed rifampicin 8 mg/kg daily; monitor liver function regularly and particularly frequently in first 2 months; see also Cautions above</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Renal impairment </h2> <p class="cT">risk of ototoxicity and peripheral neuropathy with isoniazid; prophylactic pyridoxine recommended, see <a title="BNF:target-block: Isoniazid prescribing notes" href="PHP3588-antituberculosis-drugs.htm#PHP3594">notes above</a></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Pregnancy </h2> <p class="cT">see <a title="target-block: pregnancy and breast-feeding - antituberculous drugs" href="PHP3588-antituberculosis-drugs.htm#PHP3590">Pregnancy</a>; isoniazid not known to be harmful, but prophylactic pyridoxine recommended; manufacturers advise very high doses of rifampicin teratogenic in <em>animal</em> studies in first trimester; risk of neonatal bleeding may be increased by rifampicin in third trimester</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Breast-feeding </h2> <p class="cT">see <a title="BNF:target-block: Breast-feeding - antituberculosis drugs" href="PHP3588-antituberculosis-drugs.htm#PHP3591">Breast-feeding</a>; monitor infant for possible isoniazid toxicity; theoretical risk of convulsions and neuropathy; prophylactic pyridoxine advisable in mother. Amount of rifampicin too small to be harmful</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Side-effects </h2> <p class="cT">gastro-intestinal symptoms including anorexia, nausea, vomiting, constipation, diarrhoea (antibiotic-associated colitis reported), alterations in liver function, jaundice, hepatitis (especially over age of 35 years); peripheral neuritis with high doses (pyridoxine prophylaxis, see notes above), optic neuritis, headache, drowsiness, convulsions, psychotic episodes, vertigo; blood disorders (including leucopenia, haemolytic anaemia, aplastic anaemia, eosinophilia); dry mouth; flushing, urticaria, rash (including erythema multiforme), purpura; also reported pancreatitis, oedema, interstitial pneumonitis, psychoses, hyperreflexia, hyperglycaemia, adrenal insufficiency, gynaecomastia, menstrual disturbances, difficulty with micturition, muscular weakness, myopathy, systemic lupus erythematosus-like syndrome, pellagra, exfoliative dermatitis, toxic epidermal necrolysis, Stevens-Johnson syndrome, and pemphigoid reactions; urine, saliva, and other body secretions coloured orange-red; hearing loss and tinnitus (in patients with end stage renal impairment); those occurring mainly on intermittent therapy include influenza-like symptoms (with chills, fever, dizziness, bone pain), respiratory symptoms (including shortness of breath), collapse and shock, haemolytic anaemia, thrombocytopenic purpura, disseminated intravascular coagulation, and acute renal failure; when used with tyramine or histamine rich foods, tachycardia, palpitation, hypotension, flushing, headache, dizziness, and sweating also reported</p></div> </div> <div class="cL"><h2 class="cM">Dose</h2><div class="cR"><ul><li><p>See preparations</p></li> </ul></div></div> </div><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="PHP3632-rifinah-150100.htm#PHP3632-rifinah-150100" title="Rifinah® 150/100">Rifinah® 150/100</a></li></ul><div id="PHP3633-rifinah-300150" style="margin: 0 0 0 20px;"><h1 class="title">Rifinah® 300/150 <span>(<a href="PHP10005-index-of-manufacturers.htm#PHP10320">Sanofi-Aventis</a>)</span><span> <img src="images/pom_l.png" alt="Prescription only medicine" /></span></h1><div class="cU"><p><strong>Tablets</strong>, orange, s/c, rifampicin 300 mg, isoniazid 150 mg, net price 56-tab pack = £21.02. Label: 8, 14, 22, counselling, see lenses above</p><p class="cR"><strong>Dose </strong><span class="cP">adult</span> 50 kg and over, 2 tablets daily, preferably before breakfast</p><div class="cG"><div class="cE"><h3 class="cT">Note</h3> <p class="cT">Some stock packaged as <em>Rifinah 300</em> or <em>Rifinah 150/300</em></p></div></div></div></div></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP3619-rifampicin.htm">Previous: RIFAMPICIN</a> | <a class="top" href="PHP3633-rifinah-300150.htm#">Top</a> | <a accesskey="]" href="PHP3636-streptomycin.htm">Next: STREPTOMYCIN</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>